Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 4-methoxybenzyl 3-chloromethyl-7-(2-phenylacetamido)-3-cephem-4-carboxylate
2. Mfcd00191253
3. Schembl9097187
4. Dtxsid00869417
5. 4-methoxybenzyl 3-(chloromethyl)-7-(2-phenylacetamido)-3-cephem-4-carboxylate
6. Act03151
7. Bcp31228
8. Akos015964643
9. Ac-7598
10. Ls-15044
11. Sy059948
12. Db-040515
13. Ft-0602613
14. 7-phenglacetamido-3-chloromethyl-3-cephem-4-carboxylic Acid P-methoxybenzyl Ester
15. (4-methoxyphenyl)methyl 3-(chloromethyl)-8-oxo-7-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
16. 3-(chloromethyl)-7-(phenylacetylamino)-8-oxo-1-aza-5-thiabicyclo[4.2.0]octa-2-ene-2-carboxylic Acid 4-methoxybenzyl Ester
17. 4-methoxybenzyl 3-(chloromethyl)-8-oxo-7-[(phenylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
| Molecular Weight | 487.0 g/mol |
|---|---|
| Molecular Formula | C24H23ClN2O5S |
| XLogP3 | 2.7 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 9 |
| Exact Mass | 486.1016207 g/mol |
| Monoisotopic Mass | 486.1016207 g/mol |
| Topological Polar Surface Area | 110 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 777 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
79
PharmaCompass offers a list of Gcle:Intermediate For Cephalosporin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Gcle:Intermediate For Cephalosporin manufacturer or Gcle:Intermediate For Cephalosporin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Gcle:Intermediate For Cephalosporin manufacturer or Gcle:Intermediate For Cephalosporin supplier.
PharmaCompass also assists you with knowing the Gcle:Intermediate For Cephalosporin API Price utilized in the formulation of products. Gcle:Intermediate For Cephalosporin API Price is not always fixed or binding as the Gcle:Intermediate For Cephalosporin Price is obtained through a variety of data sources. The Gcle:Intermediate For Cephalosporin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A GCLE manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of GCLE, including repackagers and relabelers. The FDA regulates GCLE manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. GCLE API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A GCLE supplier is an individual or a company that provides GCLE active pharmaceutical ingredient (API) or GCLE finished formulations upon request. The GCLE suppliers may include GCLE API manufacturers, exporters, distributors and traders.
click here to find a list of GCLE suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A GCLE DMF (Drug Master File) is a document detailing the whole manufacturing process of GCLE active pharmaceutical ingredient (API) in detail. Different forms of GCLE DMFs exist exist since differing nations have different regulations, such as GCLE USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A GCLE DMF submitted to regulatory agencies in the US is known as a USDMF. GCLE USDMF includes data on GCLE's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The GCLE USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of GCLE suppliers with USDMF on PharmaCompass.
GCLE Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of GCLE GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right GCLE GMP manufacturer or GCLE GMP API supplier for your needs.
A GCLE CoA (Certificate of Analysis) is a formal document that attests to GCLE's compliance with GCLE specifications and serves as a tool for batch-level quality control.
GCLE CoA mostly includes findings from lab analyses of a specific batch. For each GCLE CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
GCLE may be tested according to a variety of international standards, such as European Pharmacopoeia (GCLE EP), GCLE JP (Japanese Pharmacopeia) and the US Pharmacopoeia (GCLE USP).
